Drawing for SUBDELIS

USPTO serial 87214539

SUBDELIS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KAPLAN, VALERIE ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SUBDELIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Austin Padgett

AUSTIN PADGETT TROUTMAN SANDERS LLP600 PEACHTREE ST. NE, SUITE 5200ATLANTA, GA 30308UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the treatment of pain; medicines for human and veterinary purposes, namely, medicines for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the treatment of pain; Pharmaceutical preparations for use in the treatment of chemical addictionsACTIVE—
044Provision of pharmaceutical advice and information about pharmaceuticals used in the treatment and prevention of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment and prevention of co-morbidities associated with substance use disorders, for the treatment and prevention of mental health diseases and disorders, for the treatment and prevention of central nervous system disease and disorders, and for the treatment of pain; health counseling; provision of health care information and advice; provision of pharmaceutical information and advice; providing pharmaceutical information regarding medication information and treatment plansACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 10, 2018MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 10, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 9, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 7, 2018EX2GSOU EXTENSION 2 GRANTED—
May 7, 2018EXT2SOU EXTENSION 2 FILED—
May 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 25, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 23, 2017EX1GSOU EXTENSION 1 GRANTED—
Oct 23, 2017EXT1SOU EXTENSION 1 FILED—
Oct 23, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 9, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 3, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 27, 2017DOCKASSIGNED TO EXAMINER—
Oct 28, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance